ClinCalc Pro
Menu
Anti-obesity (combination)

Naltrexone with bupropion

Brand names: Mysimba

Adult dose

Dose: Titrate over 4 weeks: 1 tab AM week 1 → 1 tab AM + PM week 2 → 2 tabs AM + 1 PM week 3 → 2 tabs AM + 2 PM week 4 onwards
Route: PO
Frequency: BD

Clinical pearls

  • Adjunct to lifestyle for adults with BMI ≥30 (or ≥27 with comorbidity); NICE TA494
  • Stop at 16 weeks if <5% weight loss

Contraindications

  • Uncontrolled hypertension
  • Seizure history / risk
  • Bulimia/anorexia history
  • Severe hepatic impairment
  • Concurrent opioid use
  • Concurrent MAOI / within 14 days
  • Pregnancy

Side effects

  • Nausea (very common)
  • Constipation
  • Headache
  • Insomnia
  • Hypertension
  • Seizures
  • Suicidal ideation
  • Hepatotoxicity

Interactions

  • MAOIs (avoid)
  • Opioids
  • CYP2B6 substrates
  • Drugs lowering seizure threshold
  • Strong CYP3A4 inhibitors

Monitoring

  • BP
  • HR
  • Mental state
  • LFTs
  • Weight

Reference: BNF; NICE TA494; SmPC; https://bnf.nice.org.uk/drugs/naltrexone-with-bupropion/. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.